Source: Sanford Burnham Prebys Medical Discovery Institute From: eurekalert.org Testing may identify patients who benefit from early HER2 targeted therapy A study led by scientists at Sanford Burnham Prebys Medical Discovery Institute has identified a tumor marker that may be used to predict which breast cancer patients will experience resistance to endocrine therapy. The research offers a new approach to …
Tumor marker may help overcome endocrine treatment-resistant breast cancer
By: Sanford Burnham Prebys Medical Discovery Institute From: medicalxpress.com A study led by scientists at Sanford Burnham Prebys Medical Discovery Institute has identified a tumor marker that may be used to predict which breast cancer patients will experience resistance to endocrine therapy. The research offers a new approach to selecting patients for therapy that targets HER2, a protein that promotes …